A BEHAVIORAL-COMPARISON OF NEXUS, CATHINONE, BDB, AND MDA

被引:15
作者
BRONSON, ME
JIANG, W
DERUITER, J
CLARK, CR
机构
[1] Department of Pharmacal Sciences, School of Pharmacy, Auburn University
关键词
DESIGNER DRUGS; AMPHETAMINE DERIVATIVES; NEXUS; BDB; CATHINONE;
D O I
10.1016/0091-3057(95)00013-M
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The effects of 4-bromo-2,5-dimethoxyphenethylamine (Nexus), 3,4-methylenedioxyamphetamine (MDA), 3,4-methylenedioxyphenyl-2-butanamine (BDB), and cathinone were studied in the newly hatched chicken and compared to the effects of d-amphetamine and three hallucinogens in the same species. Cathinone, a psychomotor stimulant in man (6), produced effects that were qualitatively similar to effects seen after administration of d-amphetamine (i.e., distress vocalization, wing extension, inability to stand, and loss of righting reflex). BDB, a compound with unknown activity in man, and two known hallucinogens, Nexus (5) and MDA (1), produced effects in the chicken that are common to both stimulants and hallucinogens in this species. For example, both MDA and BDB produced abnormal body posture that was identical to that reported after administration of hallucinogens such as lysergic acid diethylamide (LSD) and harmine (11). Nexus, on the other hand, produced rigid penguin-like posture, an effect seen in the chicken after administration of another hallucinogen, mescaline (12). BDB also produced bursting forward movements, an effect commonly observed after LSD and harmine. Our findings suggest that the young chicken can be used as an alternative, nommammalian, model for predicting classification of new compounds.
引用
收藏
页码:473 / 475
页数:3
相关论文
共 12 条
[1]   EPIDEMIOLOGIC ISSUES PERTINENT TO INTERNATIONAL REGULATION OF 28 STIMULANT-HALLUCINOGEN DRUGS [J].
ANTHONY, JC ;
TRINKOFF, AM .
DRUG AND ALCOHOL DEPENDENCE, 1986, 17 (2-3) :193-211
[2]  
BRODIE BB, 1961, EXTRAPYRAMIDAL SYSTE, P183
[3]   EFFECTS OF DESIGNER DRUGS ON THE CHICKEN-EMBRYO AND 1-DAY-OLD CHICKEN [J].
BRONSON, ME ;
JIANG, WW ;
CLARK, CR ;
DERUITER, J .
BRAIN RESEARCH BULLETIN, 1994, 34 (02) :143-150
[5]   THE PHARMACOLOGY OF KHAT [J].
KALIX, P .
GENERAL PHARMACOLOGY, 1984, 15 (03) :179-187
[6]  
KILLAM EK, 1962, PHARMACOL REV, V14, P175
[7]  
MICZEK KA, 1989, PHARM TOXICOLOGY AMP, P68
[8]   LIQUID-CHROMATOGRAPHIC AND MASS-SPECTRAL ANALYSIS OF 1-(3,4-METHYLENEDIOXYPHENYL)-3-BUTANAMINES, HOMOLOGS OF 3,4-METHYLENEDIOXYAMPHETAMINES [J].
NOGGLE, FT ;
CLARK, CR ;
DERUITER, J .
JOURNAL OF CHROMATOGRAPHIC SCIENCE, 1989, 27 (05) :240-243
[9]  
PFANZ M, 1959, KLIN WOCHENSCHR, V37, P483
[10]  
SPOONER C. E., 1966, INT J NEUROPHARMACOL, V5, P217